Back to search

Article

Novel Lipid Metabolism-Related Gene Signature in Lung Adenocarcinoma Patients Experiencing Lymph Node Metastasis

2022-02-17

Abstract excerpt

Accumulating evidence revealed that lipid metabolic reprogramming facilitates lymph node metastasis and cancer progression. This study aimed to perform comprehensive bioinformatic analyses of the lipid metabolism-related impact in lung adenocarcinoma (LUAD) patients experiencing lymph node metastasis (LNM). Clinicopathological information and RNA-sequence data on LUAD patients were collected from the TCGA and GEO...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
502c772d-2995-5c3e-b075-6c43cd6f85b8
DOI
10.21203/rs.3.rs-1363802/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel Lipid Metabolism-Related Gene Signature in Lung Adenocarcinoma Patients Experiencing Lymph Node MetastasisDOI 10.21203/rs.3.rs-1363802/v1
Novel Lipid Metabolism-Related Gene Signature Associated with Clinical and Immune Features in Lung Adenocarcinoma Patients Experiencing Lymph Node MetastasisSemantic proximity
Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinomaSemantic proximity
A risk score model based on lipid metabolism-related genes could predict response to immunotherapy and prognosis of lung adenocarcinoma: a multi-dataset study and cytological validationSemantic proximity
Comprehensive analyses of metabolism-related lncRNA for LUADSemantic proximity
Effects of Lipid Metabolism-Related Genes PTGIS and HRASLS on Phenotype, Prognosis, and Tumor Immunity in Lung Squamous Cell Carcinoma.Semantic proximity
Individualized Lipid Metabolism-Associated Six-Gene Signature for Prediction of Overall Survival, Immune Infiltration, Immunotherapy Response, and Potential Candidate Drugs in Lung Squamous Cell Carcinoma Patients: Development and ValidationSemantic proximity
Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment.Semantic proximity
Development and validation of a metabolic gene signature for predicting the overall survival of patients in lung adenocarcinoma with lymph node metastasisSemantic proximity
Detection of the Fatty Acid Metabolism‐Linked Genes in Lung Adenocarcinoma as Biomarkers for Clinical Prognosis and Immunotherapeutic TargetsSemantic proximity
Fatty acid metabolism-derived prognostic model for lung adenocarcinoma: unraveling the link to survival and immune responseSemantic proximity
Lipid metabolism gene-wide profile and survival signature of lung adenocarcinomaSemantic proximity
Lipid metabolism gene-wide profile and survival signature of lung adenocarcinomaSemantic proximity
Select a neighboring publication to make it the new centre.